Management of Patients With Aortic Valve Stenosis

Mayo Clin Proc. 2018 Apr;93(4):488-508. doi: 10.1016/j.mayocp.2018.01.020.

Abstract

With increased life expectancy and aging of the population, aortic stenosis is now one of the most common valvular heart diseases. Early recognition and management of aortic stenosis are of paramount importance because untreated symptomatic severe disease is universally fatal. The advent of transcather aortic valve replacement technologies provides exciting avenues of care to patients with this disease in whom traditional surgical procedures could not be performed or were associated with high risk. This review for clinicians offers an overview of aortic stenosis and updated information on the current status of various treatment strategies. An electronic literature search of PubMed, MEDLINE, EMBASE, and Scopus was performed from conception July 1, 2016, through November 30, 2017, using the terms aortic stenosis, aortic valve replacement, transcatheter aortic valve replacement (TAVR), transcatheter aortic valve insertion (TAVI), surgical aortic valve replacement, aortic stenosis flow-gradient patterns, low-flow aortic valve stenosis, natural history, stress testing, pathophysiology, bicuspid aortic valve, and congenital aortic valve disease.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Aortic Valve Stenosis* / diagnosis
  • Aortic Valve Stenosis* / epidemiology
  • Aortic Valve Stenosis* / physiopathology
  • Aortic Valve Stenosis* / therapy
  • Cardiac Catheterization*
  • Disease Progression
  • Echocardiography, Doppler
  • Female
  • Heart Valve Prosthesis Implantation*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Male
  • Prevalence
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Severity of Illness Index

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors